Cohance Lifesciences Limited (NSE:COHANCE)
India
· Delayed Price · Currency is INR 293.50
+10.95 (3.88%)
Mar 10, 2026, 2:45 PM IST
Cohance Lifesciences Market Cap
Cohance Lifesciences has a market cap or net worth of 108.09 billion as of March 9, 2026. Its market cap has decreased by -61.03% in one year.
Market Cap
108.09B
Enterprise Value
109.97B
Revenue
10.79B
Ranking
n/a
PE Ratio
120.25
Stock Price
293.50
Market Cap Chart
Since March 9, 2020, Cohance Lifesciences's market cap has increased from 33.71M to 108.09B, an increase of 320,607.15%. That is a compound annual growth rate of 283.78%.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alivus Life Sciences | 112.31B |
| Alembic Pharmaceuticals | 139.26B |
| Strides Pharma Science | 79.85B |
| Akums Drugs and Pharmaceuticals | 73.43B |
| NATCO Pharma | 179.59B |
| Eris Lifesciences | 188.49B |
| Aarti Pharmalabs | 61.74B |
| Piramal Pharma | 201.04B |